Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 91453 · Class II · American National Red Cross, Penn Jersey Region
Key facts
| Event ID | 91453 |
|---|---|
| Recall numbers | B-0118-2023 |
| Recalling firm | American National Red Cross, Penn Jersey Region |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell product, for which donor eligibility was incomplete, was distributed. |
| Initiation date | Nov 7, 2022 |
| Report date | Jan 18, 2023 |
| Termination date | Jan 10, 2023 |
| City | Philadelphia |
| State | PA |
| Country | United States |
| FEI number | 2573021 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: